Page last updated: 2024-11-13

bacillaene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bacillaene: an inhibitor of procaryotic protein synthesis; produced by the PksX megacomplex; isolated from Bacillus subtilis; a hexaene with molecular formula C35-H48-O7 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bacillaene : A polyene antibiotic obtained from Bacillus subtilis 168 that is active against a broad spectrum of bacteria. It is notoriously unstable. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID25144999
CHEMBL ID4540312
CHEBI ID71623
MeSH IDM0254188

Synonyms (6)

Synonym
bacillaene
(3e,5e,7z)-8-({(4z,6z,8e,10e,12z,14e)-3-hydroxy-16-[(2-hydroxy-4-methylpentanoyl)amino]-4,9-dimethylhexadeca-4,6,8,10,12,14-hexaenoyl}amino)-2-methylnona-3,5,7-trienoic acid
CHEBI:71623
Q27139766
CHEMBL4540312
(3e,5e,7z)-8-[[(4z,6z,8e,10e,12z,14e)-3-hydroxy-16-[(2-hydroxy-4-methylpentanoyl)amino]-4,9-dimethylhexadeca-4,6,8,10,12,14-hexaenoyl]amino]-2-methylnona-3,5,7-trienoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
enamineAn amine RNR'R'' where R has a double bond adjacent to the amine nitrogen.
secondary alcoholA secondary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has two other carbon atoms attached to it.
polyketideNatural and synthetic compounds containing alternating carbonyl and methylene groups ('beta-polyketones'), biogenetically derived from repeated condensation of acetyl coenzyme A (via malonyl coenzyme A), and usually the compounds derived from them by further condensations, etc. Considered by many to be synonymous with the less frequently used terms acetogenins and ketides.
polyene antibioticA family of antibiotics containing a conjugated polyene moiety, usuallly isolated from some species of Streptomyces.
monocarboxylic acid amideA carboxamide derived from a monocarboxylic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1617769Antibacterial activity against Salmonella typhimurium CCARM 8250 assessed as inhibition zone at 10 mg/ml incubated for 18 hrs by radial diffusion assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
An Effective Strategy for Identification of Highly Unstable Bacillaenes.
AID1617767Antibacterial activity against Enterococcus faecium CCARM 5203 assessed as inhibition zone at 10 mg/ml incubated for 18 hrs by radial diffusion assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
An Effective Strategy for Identification of Highly Unstable Bacillaenes.
AID1617770Antibacterial activity against Enterococcus faecium CCARM 5203 assessed as reduction in bacterial growth at 12.5 ug/ml incubated for 18 hrs by serial dilution method relative to control2019Journal of natural products, 12-27, Volume: 82, Issue:12
An Effective Strategy for Identification of Highly Unstable Bacillaenes.
AID1617768Antibacterial activity against Escherichia coli CCARM 1009 assessed as inhibition zone at 10 mg/ml incubated for 18 hrs by radial diffusion assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
An Effective Strategy for Identification of Highly Unstable Bacillaenes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (3.23)18.2507
2000's6 (19.35)29.6817
2010's18 (58.06)24.3611
2020's6 (19.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.32 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index5.43 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]